An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants aged \> 18 years with CKD
Participants who are eligible for Mircera treatment according to current guidelines and summary of product characteristics (SmPC)
You may not be if
Non-renal anemia
Pregnancy and breast-feeding
Uncontrolled hypertension
Known hypersensitivity to methoxy polyethylene glycol-epoetin beta
Administration of any other study drug within 30 days prior to study enrollment
Clareo Health | An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
